OstomyCure AS is a medical technology company who has developed a revolutionary technology called Transcutaneous Implant Evacuation Solution, the TIES® Solution. The TIES® Continent Ileostomy Solution is a titanium implant solution with lid intended to replace a conventional ostomy. It allows a more carefree life for patients who suffer from inflammatory bowel diseases such as Crohn´s disease, Ulcerative colitis, cancers or other related diseases that necessitate removal of the colon (large intestine). TIES is currently in a clinical trial phase.
The company is headquartered in Oslo, Norway.
Kistefos invested in Ostomycure in 2007 and is the largest owner with 73,9% of the shares.